{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:35:53Z","timestamp":1778524553017,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"International Science and Technology Cooperation Project of Gansu Province","award":["1204WCGA023"],"award-info":[{"award-number":["1204WCGA023"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31230073"],"award-info":[{"award-number":["31230073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31172316"],"award-info":[{"award-number":["31172316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31101812"],"award-info":[{"award-number":["31101812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science Fund for Creative Research Groups of Gansu Province","award":["1210RJIA006"],"award-info":[{"award-number":["1210RJIA006"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.042","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T06:37:10Z","timestamp":1396075030000},"page":"3058-3065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Zhong-Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eskild","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Qun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Quan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.03.042_bib0005","series-title":"Toxoplasmosis of animals and humans","first-page":"1","author":"Dubey","year":"2010"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0010","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1756-3305-4-165","article-title":"Toxoplasma gondii infection in humans in China","volume":"4","author":"Zhou","year":"2011","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/427660","article-title":"A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts","volume":"191","author":"Beghetto","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0035","first-page":"214","article-title":"A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome","volume":"119","author":"Bertoli","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/erv.10.113","article-title":"Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?","volume":"9","author":"Innes","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0045","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1645\/GE-683.1","article-title":"Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers","volume":"91","author":"Dubey","year":"2005","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pt.2004.08.008","article-title":"Zoonotic protozoa: from land to sea","volume":"20","author":"Fayer","year":"2004","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives","volume":"12","author":"Zhang","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0060","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0065","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1017\/S0031182006001855","article-title":"Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora","volume":"133","author":"Innes","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/IAI.68.1.38-45.2000","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice","volume":"68","author":"Vercammen","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parint.2007.04.003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii","volume":"56","author":"Wang","year":"2007","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0080","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.vaccine.2013.01.027","article-title":"Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0085","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.4049\/jimmunol.155.10.4798","article-title":"IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii","volume":"155","author":"Kasper","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0090","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.157.5.2103","article-title":"IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice","volume":"157","author":"Khan","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0095","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/IAI.62.5.1639-1642.1994","article-title":"Interleukin-12 enhances murine survival against acute toxoplasmosis","volume":"62","author":"Khan","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4049\/jimmunol.177.1.177","article-title":"Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery","volume":"177","author":"Bolesta","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri1052","article-title":"Cytokine control of memory T-cell development and survival","volume":"3","author":"Schluns","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0110","doi-asserted-by":"crossref","first-page":"e10842","DOI":"10.1371\/journal.pone.0010842","article-title":"Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii","volume":"5","author":"Bhadra","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0115","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.4049\/jimmunol.163.8.4503","article-title":"IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii","volume":"163","author":"Khan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0120","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1174182","article-title":"IL-21 is required to control chronic viral infection","volume":"324","author":"Elsaesser","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0125","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.1175194","article-title":"A vital role for interleukin-21 in the control of a chronic viral infection","volume":"324","author":"Yi","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.gt.3302393","article-title":"Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice","volume":"12","author":"Cui","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20041057","article-title":"Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function","volume":"201","author":"Zeng","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00436-010-1742-0","article-title":"Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis","volume":"106","author":"Liu","year":"2010","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0145","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1016\/j.vaccine.2008.05.034","article-title":"Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice","volume":"26","author":"Wei","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0150","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2307\/1591566","article-title":"Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes","volume":"36","author":"Bounous","year":"1992","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/IAI.05974-11","article-title":"An inside job: hacking into Janus kinase\/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii","volume":"80","author":"Denkers","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1286-4579(99)80071-9","article-title":"T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii","volume":"1","author":"Denkers","year":"1999","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0165","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.00425-12","article-title":"The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden","volume":"80","author":"Grover","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0170","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0175","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0952-7915(00)00118-7","article-title":"DNA vaccines: a key for inducing long-term cellular immunity","volume":"12","author":"Gurunathan","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development","volume":"8","author":"Kur","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0185","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/IAI.01190-10","article-title":"Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8+ T effector memory cells specific for a human parasite, Trypanosoma cruzi","volume":"79","author":"Rigato","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0190","first-page":"549","article-title":"DNA vaccines: basic mechanism and immune responses","volume":"4","author":"Robinson","year":"1999","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0195","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0200","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/CVI.05578-11","article-title":"Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii","volume":"19","author":"Yan","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0270","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1371\/journal.pntd.0000983","article-title":"Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of genetic vaccine against Trypanosoma cruzi","volume":"5","author":"Eickhoff","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2014.03.042_bib0210","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.178.6.3492","article-title":"Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques","volume":"178","author":"Hryniewicz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0215","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1128\/IAI.71.10.6045-6048.2003","article-title":"Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin vaccination","volume":"71","author":"Umemura","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0220","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1016\/j.vaccine.2011.09.118","article-title":"Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication","volume":"29","author":"Pallikkuth","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0225","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20020369","article-title":"Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells","volume":"195","author":"Becker","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0230","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.4049\/jimmunol.168.10.4827","article-title":"Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells","volume":"168","author":"Schluns","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0235","first-page":"3877","article-title":"Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes","volume":"8","author":"Lu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/187152812800959040","article-title":"Interleukin-21 in immune and allergic diseases","volume":"11","author":"Sarra","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0245","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/j.vaccine.2009.01.137","article-title":"Coimmunization with an optimized IL-15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII","volume":"27","author":"Ramanathan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0250","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1189\/jlb.1004621","article-title":"Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-herpes simplex virus immunity","volume":"78","author":"Toka","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exppara.2011.02.005","article-title":"Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1","volume":"128","author":"Yan","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00312-10","article-title":"Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice","volume":"18","author":"Yuan","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0265","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","article-title":"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.042_bib0275","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2009.08.043","article-title":"Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice","volume":"27","author":"Peng","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T17:09:41Z","timestamp":1689095381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":54,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004113"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}